Frontiers in Cellular and Infection Microbiology

Article	Citations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development	550
Antibiotics as Major Disruptors of Gut Microbiota	397
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields	234
Role and Mechanism of Gut Microbiota in Human Disease	219
Antibiotic Resistance: One Health One World Outlook	218
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China	199
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens	196
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance	178
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species	167
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey	160
SARS-COV-2 Variants: Differences and Potential of Immune Evasion	151
The Female Vaginal Microbiome in Health and Bacterial Vaginosis	138
Periodontal Disease: The Good, The Bad, and The Unknown	129
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System	127
The Gut Microbiota in Inflammatory Bowel Disease	126
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria	123
Wuhan to World: The COVID-19 Pandemic	120
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression	113
Urinary Microbiome: Yin and Yang of the Urinary Tract	111
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine	110
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome	109
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies	100
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan	100
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics	99
Promising Therapeutic Strategies Against Microbial Biofilm Challenges	98

Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives	97
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy	97
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities	93
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro	93
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia	92
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease	91
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases	91
Gut Microbiota and Diarrhea: An Updated Review	90
Chitosan-Based Nanoparticles Against Viral Infections	89
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus	89
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection	89
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance	88
An Update on Molecular Diagnostics for COVID-19	87
Gut Microbiota Status in COVID-19: An Unrecognized Player?	86
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review	85
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy	83
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation	83
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial	82
Proteus mirabilis Biofilm: Development and Therapeutic Strategies	82
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection	80
Viral Infections, the Microbiome, and Probiotics	79
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium	77
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases	77
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic	77
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy	76
An Overview of Anti-Eukaryotic T6SS Effectors	75
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review	75
Herpes Simplex Virus Cell Entry Mechanisms: An Update	74
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches	73
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome	73
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples	72
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility	70
The Impact of Gut Microbiota on Radiation-Induced Enteritis	70
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection	68
The Microbiota of the Human Mammary Ecosystem	68
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future	67
Bacterial Vaginosis: What Do We Currently Know?	66
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing	65
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area	65
Cutaneous Malassezia: Commensal, Pathogen, or Protector?	65
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota	65
C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens	63
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen	63
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis	63
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study	63
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants	63
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease	62
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact	62
The Gut Microbiota of Critically Ill Patients With COVID-19	62
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection	62

Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota	62
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions	61
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation	61
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications	61
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	60
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species	60
Oxidative Stress and Pathogenesis in Malaria	60
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis	60
Malassezia spp. Yeasts of Emerging Concern in Fungemia	59
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases	59
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics	59
Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review	59
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy	58
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources	58
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities	58
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients	57
Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection	56
The Anti-colitis Effect of Schisandra chinensis Polysaccharide Is Associated With the Regulation of the Composition and Metabolism of Gut Microbiota	56
Shining Light on Human Gut Bacteriophages	55
Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing	55
Azole Use in Agriculture, Horticulture, and Wood Preservation – Is It Indispensable?	55
The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection	55
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer	54
Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection	54
A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection	54
Francisella tularensis, Tularemia and Serological Diagnosis	54
Planctomycetes as Host-Associated Bacteria: A Perspective That Holds Promise for Their Future Isolations, by Mimicking Their Native Environmental Niches in Clinical Microbiology Laboratories	54
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation	54
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies	54
Determinants of Vaginal Microbiota Composition	53
Neuroinflammation, Sleep, and Circadian Rhythms	53
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora	52
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach	52
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems	52
Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis	52
Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study	52
Role of Cytokines in Experimental and Human Visceral Leishmaniasis	52
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease	52
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients	51
The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis	51
The Human Skin Microbiome in Selected Cutaneous Diseases	50
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar	50
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies	50
The Oral Microbiome in Periodontal Health	50
Epidemiological Investigation and Antimicrobial Resistance Profiles of Salmonella Isolated From Breeder Chicken Hatcheries in Henan, China	50
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19	49
Amylases: Biofilm Inducer or Biofilm Inhibitor?	49
Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population	49
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway	49
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis	48
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages	48
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?	48
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections	48
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications	47
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life	47
The Dynamic Roles of the Inner Membrane Complex in the Multiple Stages of the Malaria Parasite	47
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy	46
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis	46
Extracellular Vesicles in Trypanosomatids: Host Cell Communication	46
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota	46
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome	46
Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings	46
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy	45
The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections	45
Microbial Colonization From the Fetus to Early Childhood—A Comprehensive Review	45
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)	45
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome	45
Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract	45
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic	45
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach	45
Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model	45
Acaricides Resistance in Ticks: Selection, Diagnosis, Mechanisms, and Mitigation	44
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies	44
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives	44
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae	44
Understanding bacterial biofilms: From definition to treatment strategies	44
Block and Lock HIV Cure Strategies to Control the Latent Reservoir	43
The Microbiome Composition of a Man's Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy	43
Altered Fecal Microbiota Composition in Older Adults With Frailty	43
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study	43

Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects	43
Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae	43
Role of Platelet Cytokines in Dengue Virus Infection	43
Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model	43
Synergism of Streptococcus mutans and Candida albicans Reinforces Biofilm Maturation and Acidogenicity in Saliva: An In Vitro Study	43
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals	43
Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women	43
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study	43
Gut Microbiota: Its Potential Roles in Pancreatic Cancer	42
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy	42
Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis	42
Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions	42
High-Fat Diet Induced Alteration of Mice Microbiota and the Functional Ability to Utilize Fructooligosaccharide for Ethanol Production	42
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment	42
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections	42
Analysis of Resistance to Florfenicol and the Related Mechanism of Dissemination in Different Animal-Derived Bacteria	41
Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation	41
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics	41
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets	41
Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack	41
Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2	41
Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi	41
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review	41
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants	40
Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection	40
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury	40
Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials	40
TickSialoFam (TSFam): A Database That Helps to Classify Tick Salivary Proteins, a Review on Tick Salivary Protein Function and Evolution, With Considerations on the Tick Sialome Switching Phenomenon	40
Peptidylarginine Deiminase Inhibition Abolishes the Production of Large Extracellular Vesicles From Giardia intestinalis, Affecting Host-Pathogen Interactions by Hindering Adhesion to Host Cells	40
Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography	40
Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review	40
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?	39
Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors	39
Unraveling Pseudomonas aeruginosa and Candida albicans Communication in Coinfection Scenarios: Insights Through Network Analysis	39
Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression	39
Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CD	39
Phages in the Gut Ecosystem	39
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis	39
Survival and Control of Campylobacter in Poultry Production Environment	39
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells	39
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography	39
ACE2 Shedding and the Role in COVID-19	39
Host Innate Immune Responses to Acinetobacter baumannii Infection	39
Host-Malaria Parasite Interactions and Impacts on Mutual Evolution	38
A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic	38
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review	38
Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling	38
Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing	38
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension	38
Effects of Berberine on the Gastrointestinal Microbiota	38
Lactobacillus rhamnosus Strains Relieve Loperamide-Induced Constipation via Different Pathways Independent of Short-Chain Fatty Acids	38
Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies	38
Exosomes Derived From Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by miR-92a-3p in Sepsis-Induced Acute Lung Injury	38
Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder	38
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge	37
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes	37
Aedes Mosquito Salivary Components and Their Effect on the Immune Response to Arboviruses	37
Cervical-Vaginal Microbiome and Associated Cytokine Profiles in a Prospective Study of HPV 16 Acquisition, Persistence, and Clearance	37
The Fungal Microbiome and Asthma	37
Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics	37
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus	37
Vaginal Microbiota and Cytokine Levels Predict Preterm Delivery in Asian Women	36
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?	36
Role of the PE/PPE Family in Host–Pathogen Interactions and Prospects for Anti-Tuberculosis Vaccine and Diagnostic Tool Design	36
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management	36
Bacillus amyloliquefaciens YN201732 Produces Lipopeptides With Promising Biocontrol Activity Against Fungal Pathogen Erysiphe cichoracearum	36
Structure and Function of Oral Microbial Community in Periodontitis Based on Integrated Data	36
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients	36
Comparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease	36
Pathogenic Detection by Metagenomic Next-Generation Sequencing in Osteoarticular Infections	36
Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy	35
Do Mixed-Species Biofilms Dominate in Chronic Infections?–Need for in situ Visualization of Bacterial Organization	35
Toxoplasma gondii Genotyping: A Closer Look Into Europe	35
Next-Generation Sequencing Reveals the Progression of COVID-19	35
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding	35
Emerging Evasion Mechanisms of Macrophage Defenses by Pathogenic Bacteria	35
Forensic Analysis of Human Microbiome in Skin and Body Fluids Based on Geographic Location	35
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study	35
Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis	35
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis	35
Interfering with Autophagy: The Opposing Strategies Deployed by Legionella pneumophila and Coxiella burnetii Effector Proteins	35
Global epidemiology, genetic environment, risk factors and therapeutic prospects of mcr genes: A current and emerging update	35
The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris	35
Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites	35
Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis	35
Dysfunctional Innate Immune Responses and Severe Dengue	35
Divergence of Legionella Effectors Reversing Conventional and Unconventional Ubiquitination	34
A Strong Decline in the Incidence of Childhood Otitis Media During the COVID-19 Pandemic in the Netherlands	34
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer	34
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy	34
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease	34
The Complex Interactions Between Rotavirus and the Gut Microbiota	34
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence	34
Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Su	34
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection	34